2015
DOI: 10.1016/j.jaad.2014.09.014
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous and mucocutaneous leishmaniasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
74
0
23

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 164 publications
(98 citation statements)
references
References 130 publications
1
74
0
23
Order By: Relevance
“…[3] Diffuse cutaneous leishmaniasis is common in HIV-affected patients. [4] Visceral leishmaniasis can occur as an opportunistic infection in late stages of HIV infection. About 1700 cases have been reported worldwide in 33 countries, India having the highest number of cases.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[3] Diffuse cutaneous leishmaniasis is common in HIV-affected patients. [4] Visceral leishmaniasis can occur as an opportunistic infection in late stages of HIV infection. About 1700 cases have been reported worldwide in 33 countries, India having the highest number of cases.…”
Section: Discussionmentioning
confidence: 99%
“…A study revealed that 11% of patients with HIV in Mediterranean Basin had Leishmania infantum in the bone marrow aspirates. [4] Cases of leishmaniasis have been reported within lesions of Kaposi sarcoma, squamous cell carcinoma, and basal cell carcinoma in HIV-infected patients. [6] Coinfection leads to increased treatment failure, relapse, drug toxicity, and mortality.…”
Section: Discussionmentioning
confidence: 99%
“…However, it may occasionally present with atypical presentations, such as with a zosteriform pattern, as hyperkeratotic psoriasiform, as eczematoid, or as erysipeloid, lupoid, sporotrichoid, nodular, warty, impetiginized and acneiform lesions [2]. Both typical and atypical CLs are differentiated from other dermal diseases, such as chromoblastomycosis, lobomycosis, cutaneous diphtheria, rhinoscleroma, tropical pyoderma, plaque psoriasis, psoriasis or keloids, using cytopathological or molecular methods [2,25]. …”
Section: Discussionmentioning
confidence: 99%
“…Cure rates can range widely from 52 to 95 % with antimonials [47][48][49]. Oral miltefosine may also be used in both Old World and New World disease as it has been shown to be efficacious and relatively well tolerated compared with antimonials [50]. As second-line therapy, liposomal or non-liposomal amphotericin B are effective in patients who are non-responsive to antimonials.…”
Section: Treatmentmentioning
confidence: 99%